Crossmark

High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study

Crossref DOI link: https://doi.org/10.1186/s40360-021-00529-3

Published Online: 2021-10-25

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Yanfang

Su, Wenjia

Liang, Guohua

Shan, Xiaoyu

Ma, Weiwei

Tang, Dabei

Li, Liru

Niu, Xingjian

Zhao, Shu

Zhang, Qingyuan

Zhao, Wenhui
License Information

Text and Data Mining valid from 2021-10-25

Version of Record valid from 2021-10-25
More Information

Article History

Received: 11 April 2021

Accepted: 1 October 2021

First Online: 25 October 2021

Declarations

:

: The study was approved by the Ethics Committee of The Harbin Medical University Cancer Hospital.

: All authors read and approved the final manuscript.

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below